Fig. 10From: Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitroThe potential mechanisms responsible for GPX3 downregulation in breast cancer. a The promoter methylation level of GPX3 was increased in breast cancer compared with normal controls. b The miRNA-GPX3 network. c–f The prognostic values of four miRNAs in breast cancer. g–j The expression levels of four miRNAs in breast cancer. k The intersection analysis of survival analysis and expression analysis. l The model of GPX3′s function and dysregulated mechanism in breast cancer. P < 0.05 was considered as statistically significantBack to article page